Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $110.80 billion. The enterprise value is $118.04 billion.
| Market Cap | 110.80B |
| Enterprise Value | 118.04B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, before market open.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.47 billion shares outstanding. The number of shares has increased by 2.47% in one year.
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +2.47% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 92.76% |
| Float | 1.47B |
Valuation Ratios
The trailing PE ratio is 63.19 and the forward PE ratio is 31.66. BSX's PEG ratio is 1.80.
| PE Ratio | 63.19 |
| Forward PE | 31.66 |
| PS Ratio | 7.46 |
| Forward PS | 6.76 |
| PB Ratio | 5.51 |
| P/FCF Ratio | 63.51 |
| PEG Ratio | 1.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.47, with an EV/FCF ratio of 68.31.
| EV / Earnings | 66.84 |
| EV / Sales | 8.03 |
| EV / EBITDA | 32.47 |
| EV / EBIT | 48.78 |
| EV / FCF | 68.31 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.67 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 2.92 |
| Debt / FCF | 6.15 |
| Interest Coverage | 8.96 |
Financial Efficiency
Return on equity (ROE) is 9.30% and return on invested capital (ROIC) is 6.65%.
| Return on Equity (ROE) | 9.30% |
| Return on Assets (ROA) | 5.10% |
| Return on Capital (ROIC) | 6.65% |
| Revenue Per Employee | $306,396 |
| Profits Per Employee | $36,792 |
| Employee Count | 48,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.96 |
Taxes
In the past 12 months, BSX has paid $377.00 million in taxes.
| Income Tax | 377.00M |
| Effective Tax Rate | 17.59% |
Stock Price Statistics
The stock price has increased by +40.50% in the last 52 weeks. The beta is 0.77, so BSX's price volatility has been lower than the market average.
| Beta (1Y) | 0.77 |
| 52-Week Price Change | +40.50% |
| 50-Day Moving Average | 69.87 |
| 200-Day Moving Average | 59.67 |
| Relative Strength Index (RSI) | 69.93 |
| Average Volume (30 Days) | 6,228,345 |
Short Selling Information
The latest short interest is 13.94 million, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 13.94M |
| Short Previous Month | 12.43M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 2.02 |
Income Statement
In the last 12 months, BSX had revenue of $14.71 billion and earned $1.77 billion in profits. Earnings per share was $1.19.
| Revenue | 14.71B |
| Gross Profit | 10.19B |
| Operating Income | 2.46B |
| Pretax Income | 2.15B |
| Net Income | 1.77B |
| EBITDA | 3.64B |
| EBIT | 2.42B |
| Earnings Per Share (EPS) | $1.19 |
Balance Sheet
The company has $2.33 billion in cash and $10.62 billion in debt, giving a net cash position of -$8.29 billion or -$5.64 per share.
| Cash & Cash Equivalents | 2.33B |
| Total Debt | 10.62B |
| Net Cash | -8.29B |
| Net Cash Per Share | -$5.64 |
| Equity / Book Value | 19.93B |
| Book Value Per Share | 13.55 |
| Working Capital | 3.27B |
Cash Flow
In the last 12 months, operating cash flow was $2.48 billion and capital expenditures -$749.00 million, giving a free cash flow of $1.73 billion.
| Operating Cash Flow | 2.48B |
| Capital Expenditures | -749.00M |
| Free Cash Flow | 1.73B |
| FCF Per Share | $1.18 |
Margins
Gross margin is 69.30%, with operating and profit margins of 16.75% and 12.01%.
| Gross Margin | 69.30% |
| Operating Margin | 16.75% |
| Pretax Margin | 14.62% |
| Profit Margin | 12.01% |
| EBITDA Margin | 24.72% |
| EBIT Margin | 16.45% |
| FCF Margin | 11.75% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.47% |
| Shareholder Yield | -2.47% |
| Earnings Yield | 1.61% |
| FCF Yield | 1.57% |
Analyst Forecast
The average price target for BSX is $75.32, which is -0.11% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $75.32 |
| Price Target Difference | -0.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | 9.84% |
| EPS Growth Forecast (5Y) | 28.10% |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 6, 2003 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 4.77 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 7 |